Browse > Article
http://dx.doi.org/10.4014/jmb.1304.04011

Evaluation of Macroporous and Microporous Carriers for CHO-K1 Cell Growth and Monoclonal Antibody Production  

Rodrigues, Maria Elisa (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Costa, Ana Rita (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Fernandes, Pedro (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Henriques, Mariana (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Cunnah, Philip (Biotecnol)
Melton, David W. (Edinburgh Cancer Research Centre, University of Edinburgh)
Azeredo, Joana (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Oliveira, Rosario (IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho)
Publication Information
Journal of Microbiology and Biotechnology / v.23, no.9, 2013 , pp. 1308-1321 More about this Journal
Abstract
The emergence of microcarrier technology has brought a renewed interest in anchorage-dependent cell culture for high-yield processes. Well-known in vaccine production, microcarrier culture also has potential for application in other fields. In this work, two types of microcarriers were evaluated for small-scale monoclonal antibody (mAb) production by CHO-K1 cells. Cultures (5 ml) of microporous Cytodex 3 and macroporous CultiSpher-S carriers were performed in vented conical tubes and subsequently scaled-up (20 ml) to shake-flasks, testing combinations of different culture conditions (cell concentration, microcarrier concentration, rocking methodology, rocking speed, and initial culture volume). Culture performance was evaluated by considering the mAb production and cell growth at the phases of initial adhesion and proliferation. The best culture performances were obtained with Cytodex 3, regarding cell proliferation (average $1.85{\pm}0.11{\times}10^6$ cells/ml against $0.60{\pm}0.08{\times}10^6$ cells/ml for CultiSpher-S), mAb production ($2.04{\pm}0.41{\mu}g/ml$ against $0.99{\pm}0.35{\mu}g/ml$ for CultiSpher-S), and culture longevity (30 days against 10-15 days for CultiSpher-S), probably due to the collagen-coated dextran matrix that potentiates adhesion and prevents detachment. The culture conditions of greater influence were rocking mechanism (Cytodex 3, pulse followed by continuous) and initial cell concentration (CultiSpher-S, $4{\times}10^5$ cells/ml). Microcarriers proved to be a viable and favorable alternative to standard adherent and suspended cultures for mAb production by CHO-K1 cells, with simple operation, easy scale-up, and significantly higher levels of mAb production. However, variations of microcarrier culture performance in different vessels reiterate the need for optimization at each step of the scale-up process.
Keywords
Monoclonal antibody; microcarrier; Cytodex 3; CultiSpher-S; Chinese hamster ovary cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Auni s JG, Bader B, Caola A, Griffiths J, Katz M, Licari P, et al. 2003. Fluid mechanics, cell distribution, and environment in cell cube bioreactors. Biotechnol. Prog. 19: 2-8.   DOI   ScienceOn
2 Almgren J, Nilsson C, Peterson AC, Nilsson K. 1991. Cultispher-macroporous gelatine microcarrier - new applications, pp. 434-438. In Spier RE, Griffiths JB, Meignier B (eds.). Production of Biologicals from Animal Cells in Culture. Butterworth-Heinemann, Oxford.
3 Andersen DC, Krummen L. 2002. Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 13: 117-123.   DOI   ScienceOn
4 Andersen DC, Reilly DE. 2004. Production technologies for monoclonal antibodies and their fragments. Curr. Opin. Biotechnol. 15: 456-462.   DOI   ScienceOn
5 Butler M. 1996. Modes of culture for high cell densities, pp. 175-194. In Butler M (ed.). Animal Cell Culture and Technology. Taylor and Francis, Routledge, UK.
6 Berry JM, Barnabe N, Coombs KM, Butler M. 1999. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol. Bioeng. 62: 12-19.   DOI   ScienceOn
7 Bluml G. 2007. Microcarrier cell culture technology, pp. 149-178. In Portner R (ed.). Animal Cell Biotechnology: Methods and Protocols, 2nd Ed. Humana Press Inc., Totowa, NJ.
8 Butler M. 1987. Growth limitations in microcarrier cultures. Adv. Biochem. Eng. 34: 57-84.
9 Cadic C, Dupuy B, Pianet I, Merle M, Margerin C, Bezian JH. 1992. In vitro culture of hybridoma cells in agarose beads producing antibody secretion for two weeks. Biotechnol. Bioeng. 39: 108-112.   DOI
10 Carcagno CM, Criscuolo M, Melo C, Vidal JA. 2000. Method for the massive culture of cells producing recombinant human erythropoietin. US Patent WO/2000/027997.
11 Chiou TW, Murakami S, Wang DIC, Wu WT. 1991. A fiberbed bioreactor for anchorage-dependent animal cell cultures. I. Bioreactor design and operations. Biotechnol. Bioeng. 37: 755-761.   DOI
12 Chu L, Robinson DK. 2001. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 12: 180-187.   DOI   ScienceOn
13 Costa AR, Rodrigues ME, Henriques M, Melton D, Cunnah P, Oliveira R, et al. 2012. Evaluation of the $OSCA^{TM}$ system for the production of monoclonal antibodies by CHO-K1 cells. Int. J. Pharm. 430: 42-46.   DOI   ScienceOn
14 Griffiths B. 2007. The development of animal cell products: history and overview, pp. 1-14. In Stacey G, Davis J (eds.). Medicines from Animal Cell Culture. John Wiley & Sons, Chichester.
15 Del Guerra S, Bracci C, Nilsson K, Belcourt A, Kessler L, Lupi R, et al. 2001. Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: preparation, in vitro characterization, and microencapsulation. Biotechnol. Bioeng. 75: 741-744.   DOI   ScienceOn
16 Genzel Y, Reichl U. 2007. Vaccine production: state of the art and future needs in upstream processing, pp. 457-473. In Portner R (ed.). Animal Cell Biotechnology: Methods and Protocols. Humana Press, NJ.
17 Griffiths B. 1990. Perfusion systems for cell cultivation, pp. 217-250. In Lubiniecki AS (ed.). Large-scale Mammalian Cell Culture Technology. CRC Press.
18 Hirtenstein M, Clark J, Lindgren G, Vretblad P. 1980. Microcarriers for animal cell culture: a brief review of theory and practice. Dev. Biol. Stand. 46: 109-116.
19 Ho L, Greene CL, Schmidt AW, Huang LH. 2004. Cultivation of HEK 293 cell line and production of a member of the superfamily of g-protein coupled receptors for drug discovery applications using a highly efficient novel bioreactor. Cytotechnology 45: 117-123.   DOI   ScienceOn
20 Hu X, Xiao C, Huang Z, Guo Z, Zhang Z, Li Z. 2000. Pilot production of u-PA with porous microcarrier cell culture. Cytotechnology 33: 13-19.   DOI   ScienceOn
21 Klement G, Scheirer W, Katinger HW. 1987. Construction of a large scale membrane reactor system with different compartments for cells, medium and product. Dev. Biol. Stand. 66: 221-226.
22 Kong D, Chen M, Gentz R, Zhang J. 1999. Cell growth and protein formation on various microcarriers. Cytotechnology 29: 151-158.   DOI   ScienceOn
23 Nilsson K, Buzsaky F, Mosbach K. 1986. Growth of anchoragedependent cells on macroporous microcarriers. Nat. Biotechnol. 4: 989-990.   DOI
24 Lee GM, Varma A, Palsson BO. 1991. Production of monoclonal antibody using free-suspended and immobilized hybridoma cells: effect of serum. Biotechnol. Bioeng. 38: 821-830.   DOI   ScienceOn
25 Li X, Liu T, Song K, Yao L, Ge D, Bao C, et al. 2006. Culture of neural stem cells in calcium alginate beads. Biotechnol. Prog. 22: 1683-1689.   DOI
26 Mendonca R, Ioshimoto L, Mendonca R, De-Franco M, Valentini E, Becak W, et al. 1993. Preparation of human rabies vaccine in VERO cell culture using a microcarrier system. Braz. J. Med. Biol. Res. 26: 1305-1317.
27 Ozturk SS, Hu WS. 2006. Cell Culture Technology for Pharmaceutical and Cell-based Therapies. CRC Press, NY.
28 Reuveny S, Thoma RW. 1986. Apparatus and methodology for microcarrier cell culture, pp. 139-179. In Allen IL (ed.). Advances in Applied Nicrobiology. Academic Press.
29 Rudolph G, Lindner P, Gierse A, Bluma A, Martinez G, Hitzmann B, et al. 2008. Online monitoring of microcarrier based fibroblast cultivations with in situ microscopy. Biotechnol. Bioeng. 99: 136-145.   DOI   ScienceOn
30 Rupp RG. 1985. Use of cellular micro-encapsulation in large-scale production of monoclonal antibodies., pp. 19-8. In Feder J, Tolbert WR (eds.). Large-scale Mammalian Cell Culture. Academic Press, Orlando.
31 Scheirer W. 1988. High-density growth of animal cells within cell retention fermenters equipped with membranes, pp. 263-81. In Spier RE, Griffiths JB (eds.). Animal Cell Biotechnology. Academic Press, London.
32 Schurch U, Cryz SJ, Lang AB. 1992. Scale-up and optimization of culture conditions of a human heterohybridoma producing serotype-specific antibodies to Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 37: 446-450.
33 Varani J, Piel F, Josephs S, Beals T, Hillegas W. 1998. Attachment and growth of anchorage-dependent cells on a novel, charged-surface microcarrier under serum-free conditions. Cytotechnology 28: 101-109.   DOI   ScienceOn
34 Unger DR, Muzzio FJ, Aunins JG, Singhvi R. 2000. Computational and experimental investigation of flow and fluid mixing in the roller bottle bioreactor. Biotechnol. Bioeng. 70: 117-130.   DOI   ScienceOn
35 Valdes R, Ibarra N, Gonzalez M, Alvarez T, Garcia J, Llambias R, et al. 2001. CB.Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor. Cytotechnology 35: 145-154.   DOI   ScienceOn
36 Van Wezel AL. 1967. Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature 216: 64-65.   DOI   ScienceOn
37 Velez JO, Russell BJ, Hughes HR, Chang GJJ, Johnson BW. 2008. Microcarrier culture of COS-1 cells producing Japanese encephalitis and dengue virus serotype 4 recombinant viruslike particles. J. Virol. Methods 151: 230-236.   DOI   ScienceOn
38 Voigt A, Zintl F. 1999. Hybridoma cell growth and antineuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers. J. Biotechnol. 68: 213-226.   DOI   ScienceOn
39 Wang G, Zhang W, Friedman D, Eppstein L, Kadouri A. 1992. Continuous production of monoclonal antibodies in Celligen packed bed reactor using Fiber-Cel carrier, pp. 460-464. In Spier RE, Griffiths JB, MacDonald C (eds.). Animal Cell Technology: Developments, Process and Products. Butterworth-Heinemann, Oxford.
40 Wang MD, Yang M, Huzel N, Butler M. 2002. Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. Biotechnol. Bioeng. 77: 194-203.   DOI   ScienceOn
41 Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22: 1393-1398.   DOI   ScienceOn
42 Yamaguchi M, Shirai Y, Inouye Y, Shoji M, Kamei M, Hashizume S, et al. 1997. Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles. Cytotechnology 23: 5-12.   DOI   ScienceOn
43 Wang Y, Ouyang F. 1999. Bead-to-bead transfer of Vero cells in microcarrier culture. Bioproc. Biosyst. Eng. 21: 211-213.   DOI
44 Werner A, Duvar S, Muthing J, Buntemeyer H, Lunsdorf H, Strauss M, et al. 2000. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol. Bioeng. 68: 59-70.   DOI   ScienceOn
45 Wu SC, Huang GYL. 2002. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Biotechnol. Prog. 18: 124-128.   DOI   ScienceOn
46 Yang ST, Luo J, Chen C. 2004. A fibrous-bed bioreactor for continuous production of monoclonal antibody by hybridoma. Adv. Biochem. Eng. Biotechnol. 87: 61-96.
47 Yoon SK, Hong JK, Choo SH, Song JY, Park HW, Lee GM. 2006. Adaptation of Chinese hamster ovary cells to low culture temperature: cell growth and recombinant protein production. J. Biotechnol. 122: 463-472.   DOI   ScienceOn
48 Zhang S, Thwin C, Wu Z, Cho T, Gallagher S. 2000. An improved method for the production and purification of adenoviral vectors. US Patent WO/2000/032754.
49 Ziao C, Huang Z, Li W, Hu X, Qu W, Gao L, et al. 2002. High density and scale-up cultivation of recombinant Cho cell line and hybridomas with porous microcarrier cytopore, pp. 389-393. In Merten OW, Perrin P, Griffiths B (eds.). New Developments and New Applications in Animal Cell Technology. Lavoisier.